Department of Health and Human Services
National Institutes of Health
Toggle navigation
Home
About the Clinical Center
Clinical Trials & You
Participate in a Study
Referring a Patient
Help & Search Tips
Contact Us
National Institute of Mental Health (NIMH)s
National Institute of Mental Health (NIMH)
68 Protocols (51 Active Accrual of new subjects, 17 Follow-up of previously enrolled subjects)
000978-M:
State-Dependent Interoception, Value-Based Decision-Making, and Introspection
000942-M:
A Cognitive Test Battery for Intellectual Disabilities
000776-M:
An Open Trial of Transcranial Magnetic Stimulation for Youth with Treatment-Resistant Major Depressive Disorder
000754-M:
NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder
000676-M:
[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET
000527-M:
CNS Correlates of Extended Sleep Restriction
000101-M:
An Investigation of the Antidepressant Effects of the mGlu2/3 receptor antagonist TS-161 in Treatment-Resistant Depression
21-M-0031:
A Feasibility Study of Transcranial Electric Stimulation Therapy (TEST) for treatment resistant depression (TRD)
21-M-0018:
Characterization of an Optically Pumped Magnetometer (OPM) Magnetoencephalography (MEG) Array
20-M-0166:
Electrophysiologic Sleep Phenotyping and Sleep-Dependent Neuro-maturation in Clinical and Healthy Pediatric Populations
20-M-0159:
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
20-M-0157:
PET Imaging of Cyclooxygenase in Participants with Major Depressive Disorder (MDD)
20-M-0082:
Phase 1 Study: PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
20-M-0066:
Validating the Ask Suicide-Screening Questions (ASQ) for Youth with Autism Spectrum and Neurodevelopmental Disorders
19-M-0107:
The Mechanism of Action Underlying Ketamine's Antidepressant Effects: An Investigation of the AMPA Throughput Theory in Patients with Treatment-Resistant Major Depression
19-M-0079:
Evaluation of a Novel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal Conditions
19-M-0073:
Safety and Feasibility of Individualized Low Amplitude Seizure Therapy (iLAST)
18-M-0144:
The Effects of an ER Beta Agonist (Lilly Compound LY500307) on Estradiol-withdrawal-induced Mood Symptoms in Women with Past Perimenopausal Depression
18-M-0037:
Characterization and Treatment of Adolescent Depression
18-M-0015:
Development of Non-Invasive Brain Stimulation Techniques
17-M-0147:
Concurrent fMRI-guided rTMS and Cognitive Therapy for the Treatment of Major Depressive Episodes
17-M-0060:
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
15-M-0188:
The Neurobiology of Suicide
15-M-0182:
Psychological Treatments for Youth with Severe Irritability
15-M-0139:
Mapping the Genotype, Phenotype, and Natural History of Phelan McDermid Syndrome
15-M-0109:
Checking out Checking In: The Development and Validation of an Electronic Screening Tool for Pediatric Psychosocial Distress
15-M-0066:
Influence on Plasticity of Brain Temperature
13-M-0028:
Diagnosis of Childhood-onset Behavioral Disorders, Neuropsychiatric Disorders and Neurodevelopmental Disorders
12-M-0128:
TMS Investigations of the Human Visual System
11-M-0251:
A Longitudinal Investigation of the Endocrine and Neurobiologic Events Accompanying Puberty
11-M-0045:
Development of Magnetic Resonance Spectroscopic Imaging Techniques for Imaging Metabolites in Human Brain and Muscle
10-M-0112:
Defining the Brain Phenotype of Children with 7q11.23 Copy Number Variation, Including Williams Syndrome and 7q11.23 Duplication Syndrome
10-M-0047:
Top-Down Attentional Control of Visual-Processing
09-M-0176:
Functional Relevance of Dopamine Receptors in Healthy Controls and Patients with Schizophrenia: Characterization through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography
07-M-0021:
Development of Functional and Structural Magnetic Resonance Imaging Techniques for the Study of Mood and Anxiety Disorders
06-M-0065:
Neurodevelopmental and Behavioral Phenotyping Screening Protocol
05-M-0144:
MRS (Magnetic Resonance Spectroscopy) Measurement of Glutamate and GABA Metabolism in Brain
03-M-0211:
Family Study of Affective and Anxiety Spectrum Disorders
03-M-0186:
The Psychobiology of Temperament: An fMRI Study
02-M-0021:
Characterization and Pathophysiology of Severe Mood and Behavioral Dysregulation in Children and Youth
01-M-0254:
The Evaluation of Patients with Mood and Anxiety Disorders and Healthy Volunteers
01-M-0232:
Positron Emission Tomography (PET) Scanning in Dopamine Disorders: Parkinson's Disease and Schizophrenia
01-M-0192:
Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
00-M-0085:
Structural and Functional Imaging of Neuropsychiatric Patients and Normal Volunteers with 3.0 Tesla MRI and Magnetoencephalography (MEG)
95-M-0150:
A Neurobiological Investigation of Patients with Schizophrenia Spectrum Disorders and Their Siblings
95-M-0097:
An Endocrine Model for Postpartum Mood Disorders
93-M-0170:
Regional Cerebral Blood Flow Studies of Object Perception, Identification, Localization, and Memory
89-M-0160:
Inpatient Evaluation of Neuropsychiatric Patients
89-M-0006:
Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers
81-M-0126:
The Evaluation of Women with Menstrually Regulated Mood and Behavioral Disorders
80-M-0083:
Bipolar Genetics: A Collaborative Study
000824-M:
[11C]-(R)-Rolipram to Measure cAMP Signaling Before and After Ketamine
000674-M:
Assessment of [18F]SF12051 for Imaging the 18-kDa Translocator Protein (TSPO) in Brain and Whole Body of Healthy Subjects
000483-M:
PET Imaging of Cyclooxygenases in Multiple Sclerosis
000378-M:
Identifying Decision Making Parameters in Healthy Volunteers (HV) and Anxiety Patients (AD)
19-M-0054:
Mapping the Phenotype in Adults with Phelan-McDermid Syndrome
17-M-0181:
Recruitment and Characterization of Healthy Research Volunteers for NIMH Intramural Studies
17-M-0179:
Evaluation of a Novel PET Radioligand to Image Cyclooxygenase-1 (COX-1)
15-M-0151:
An Investigation of the Antidepressant Effects of the Glycine Receptor Antagonist AV 101 (4-chlorokynurenine) in Major Depressive Disorder
10-M-0027:
Cognitive Neuroscience of Autism Spectrum Disorders
06-M-0214:
PET Measurement of Regional Rates of Cerebral Protein Synthesis in Subjects with Fragile X Syndrome
02-M-0321:
fMRI Investigation of Explicit Cue and Contextual Fear
01-M-0185:
Effects of Arousal and Stress on Classical Conditioning
00-M-0198:
The Phenomenology and Neurophysiology of Affective Dysregulation in Children and Adolescents with Bipolar Disorder
92-M-0174:
The Central Nervous System Effects of Pharmacologically Induced Hypogonadotropic Hypogonadism with and without Estrogen and Progesterone Replacement
90-M-0088:
The Treatment of Menstrually-Related Mood Disorders with the Gonadotropin Releasing Hormone (GnRH) Agonist, Depot Leuprolide Acetate (Lupron)
90-M-0014:
Studies of Frontal Lobe Function During Cognitive Stimulation as Measured with Oxygen-15 Water Positron Emission Tomography in Normal Subjects and Patients with Neuropsychiatric Disorders
88-M-0131:
The Evaluation of Women with Perimenopause-Related Mood and Behavioral Disorders